Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term head and neck cancer. Found 24 abstracts

paginate
Avkshtol V, Handorf EA, Ridge JA, Leachman BK, Liu JC, Bauman J, Galloway TJ. Examining adjuvant radiation dose in head and neck squamous cell carcinoma. Head & neck. 2019 Jul;41(7):2133-42.
Fakhry C, Zhang Q, Gillison ML, Nguyen-Tan PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SS, Spencer S, Fortin A, Raben D, Harris J, Le QT. Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials. Cancer. 2019 Jun 15;125(12):2027-38.   PMCID: PMC6594017
Jones EA, Shuman AG, Egleston BL, Liu JC. Common Pitfalls of Head and Neck Research Using Cancer Registries. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2019 Aug;161(2):245-50.
Van Cleave JH, Fu MR, Bennett AV, Persky MS, Li Z, Jacobson A, Hu KS, Most A, Concert C, Kamberi M, Mojica J, Peyser A, Riccobene A, Tran A, Persky MJ, Savitski J, Liang E, Egleston BL. The development, usability, and reliability of the Electronic Patient Visit Assessment (ePVA) for head and neck cancer. mHealth. 2019 Jan;5:21.   PMCID: PMC6691072
Tamaki A, Miles BA, Lango M, Kowalski L, Zender CA. AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer. Head & neck. 2018 Jan;40(1):170-81.
Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, Le QT, Raben D, Strome SE, Lynn J, Malik S. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. 2017 Apr;123(7):1259-71.   PMCID: PMC5705038
Gaponova AV, Deneka AY, Beck TN, Liu H, Andrianov G, Nikonova AS, Nicolas E, Einarson MB, Golemis EA, Serebriiskii IG. Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin. Oncotarget. 2017 Mar 21;8(12):19156-71.   PMCID: PMC5386675
Liederbach E, Kyrillos A, Wang CH, Liu JC, Sturgis EM, Bhayani MK. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma. International journal of cancer. 2017 Feb;140(3):504-12.
Liu JC. Commentary on Shenson et al, "Effect of Preoperative Counseling on Hospital Length of Stay and Readmissions after Total Laryngectomy". Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2017 Feb;156(2):203-4.
Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA: a cancer journal for clinicians. 2017 Mar;67(2):122-37.
Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA: a cancer journal for clinicians. 2017 Jan 27;.
Thompson MD, Lubet RA, McCormick DL, Clapper ML, Bode AM, Juliana MM, Moeinpour F, Grubbs CJ. Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer. Oncology Letters. 2017 Sep;14(3):3480-6.   PMCID: PMC5587978
Beck TN, Kaczmar J, Handorf E, Nikonova A, Dubyk C, Peri S, Lango M, Ridge JA, Serebriiskii IG, Burtness B, Golemis EA, Mehra R. Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck. Oncotarget. 2015 Aug 07;6(22):18863-74.   PMCID: 4662460
Kaczmar J, Mehra R. HPV-negative head and neck squamous cell carcinomas: how can we use the tumor protein signature?. Biomark Med. 2015 Mar;9(3):183-5.
Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder DB, Ridge JA. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database. Cancer. 2015 Apr 15;121(8):1204-13.
Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer. 2014 Mar 15;120(6):840-7.   PMCID: Pmc3951722
Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE. Mucosal Melanoma of the Head and Neck. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):320-38.   PMCID: not NIH Funded
Andrews G, Lango M, Cohen R, Feigenberg S, Burtness B, Mehra R, Ahmed S, Nicolaou N, Gaughan J, Ridge JA. NONSURGICAL MANAGEMENT OF OROPHARYNGEAL, LARYNGEAL, AND HYPOPHARYNGEAL CANCER: THE FOX CHASE CANCER CENTER EXPERIENCE. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2011 Oct;33(10):1433-40.   PMCID: Not NIH Funded
Argiris A, Ghebremichael M, Burtness B, Axelrod RS, Deconti RC, Forastiere AA. A Phase 2 Trial of Bortezomib Followed by the Addition of Doxorubicin at Progression in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck A Trial of the Eastern Cooperative Oncology Group (E1303). Cancer. 2011 Aug;117(15):3374-82.   PMCID: PMC3135694
Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ. National cancer Database report on cancer of the head and neck: 10-year update. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2009 Jun;31(6):748-58.
Siddiqui F, Pajak TF, Watkins-Bruner D, Konski AA, Coyne JC, Gwede CK, Garden AS, Spencer SA, Jones C, Movsas B. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: A radiation therapy oncology group analysis. International Journal of Radiation Oncology Biology Physics. 2008 Feb;70(2):353-60.
Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. International Journal of Radiation Oncology Biology Physics. 2000 Aug;48(1):7-16.
Fu KK, Pajak TF, Marcial VA, Ortiz HG, Rotman M, Asbell SO, Coia LR, Vora NL, Byhardt R, Rubin P, Sorgen SD, Cox JD, Stetz J. Late Effects of Hyperfractionated Radiotherapy for Advanced Head and Neck-Cancer - Long-Term Follow-up Results of Rtog-83- 13. International Journal of Radiation Oncology Biology Physics. 1995 Jun 15;32(3):577-88.
Knudson Jr A. Genetics of tumors of the head and neck. Archives of Otolaryngology - Head and Neck Surgery. 1993 Jan;119(7):735-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term head and neck cancer

head and neck cancer cancer Head and Neck Neoplasms oropharynx Male Middle Aged Aged pathology Female human papillomavirus (HPV) human papillomavirus Squamous Cell Carcinoma hyperfractionation American Joint Committee on Cancer (AJCC) extranodal extension survival radiation-therapy radiation Adult prognosis depth of invasion staging therapy human papillomavirus-associated cancer etiology 80 and over Aged fractionation biomarkers unbalanced therapeutic deescalation laryngeal cancer cells biopsy Attitude to Health late effects chemotherapeutic-agents Seer BREAST-CANCER guidelines locally advanced head kit mutation prevention FUNCTIONAL ASSESSMENT Combined Modality Therapy complications accelerated fractionation clinical trials Cdk4 treatment time Papillomaviridae Monoclonal Antibodies psychology trials stage-iii ii trial adverse effects squamous-cell carcinomas usability virology facility type Cohort Studies dysphagia Risk salivary-gland carcinomas 1987 arlson me-journal of chronic diseases-v40-p373 united-states TONSIL postoperative kappa-b-alpha DNA damage response platinating agents immunotherapy CHEMOTHERAPY PROSTATE-CANCER Cancer Care Facilities National Cancer Data Base colon cancer Immunologic Factors cancer registry data analysis National Cancer Database NCCN Guidelines checkpoint inhibitors postoperative radiotherapy oropharyngeal Rb1 One more therapeutic deintensification Chemoradiotherapy epidemiology urinary bladder cancer SURVIVAL Oropharyngeal Neoplasms recursive partititioning analysis smoking VALIDITY Continental Population Groups radiation therapy NCCN Clinical Practice Guidelines oropharyngeal cancer submission Multivariate Analysis toxicity Ncdb Oropharynx pitfalls Radiation Therapy Oncology Group (RTOG) CELL LUNG-CANCER progression-free survival HUMAN-PAPILLOMAVIRUS Local Neoplasm Recurrence comorbidity index predict local-control E2f Nonparametric Statistics mortality Weight Loss Clinical Trials as Topic satisfaction carcinomas organ preservation proteasome inhibitor ps-341 Pain laryngectomy growth-factor resistance chemotherapy health-related quality of life squamous cell carcinoma improved survival genetics Prospective Studies function Prevalence Treatment Outcome neck-cancer digestive tracts p16 negative doxorubicin methods national cancer database conventional radiotherapy prognostic CARCINOMA locoregional control errors nationwide adjuvant therapy adenoid cystic carcinoma mucosal melanoma
Last updated on Wednesday, February 05, 2020